June 1, 2012
/PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the Jefferies 2012 Global Healthcare Conference on
Wednesday, June 6
9:00 a.m. Eastern Time
New York, NY
A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at
. Replays of the presentation will be available at the same location for 90 days following the presentation.
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed and commercialized DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with
-associated diarrhea (CDAD). Optimer has also received marketing authorization for fidaxomicin tablets in the European Union under the trade name DIFICLIR™. The company is seeking marketing authorization for fidaxomicin in
and is exploring marketing authorization in other parts of the world where
has emerged as a serious health problem, including
. Additional information can be found at
Optimer Pharmaceuticals, Inc.
, VP of Investor Relations and Corporate Communications(858) 964-3418
Jason I. Spark
, Senior Vice President619-849-6005
SOURCE Optimer Pharmaceuticals, Inc.